97 Results

People

  1. Hellmann
    Hellmann
  2. Rosenberg
    Rosenberg
  3. Rekhtman
    Rekhtman
  4. Rizvi
    Rizvi
  5. Funt
    Funt
  6. Travis
    Travis
  7. Chaft
    Chaft
  8. Chen
    Chen
  9. D'Angelo
    D'Angelo
  10. Iyer
    Iyer

Groups

  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (20)
  5. GSK Faculty (16)
  6. Hematologic Malignancies, Division of (16)
  7. Weinberg Fellows (14)
  8. Sloan Kettering Institute Postdocs (13)
  9. Genitourinary Oncology Service (12)
  10. Gastrointestinal Oncology Service (11)
  1. "pd-l1"
Formats
  1. Journal Article (67)
  2. Meeting Abstract (13)
  3. Review (13)
  4. Book Section (2)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (20)
  5. GSK Faculty (16)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Matthew Hellmann (10)
  2. Jamie Chaft (6)
  3. Jonathan Rosenberg (6)
  4. Naiyer Rizvi (5)
  5. Natasha Rekhtman (5)
  6. Geoffrey Ku (4)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Journal of Thoracic Oncology (16)
  2. Annals of Oncology (9)
  3. Journal for ImmunoTherapy of Cancer (4)
  4. Current Oncology Reports (3)
  5. Future Oncology (3)
  6. Modern Pathology (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Oxford University Press (11)
  3. Biomed Central Ltd (7)
  4. Springer (6)
  5. Future Medicine (5)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
    Journal Article

    Kowanetz, M.; Zou, W.; Gettinger, S. N.; Koeppen, H.; Kockx, M.; Schmid, P.; Kadel, E. E. 3rd; Wistuba, I.; Chaft, J.; Rizvi, N. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: A report on the successful treatment of a rare malignancy
    Journal Article

    Lattanzi, M.; Deng, F. M.; Chiriboga, L. A.; Femia, A. N.; Meehan, S. A.; Iyer, G.; Voss, M. H.; Sundatova, Y.; Huang, W. C.; Balar, A. V.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Checkpoint inhibitors in the treatment of breast cancer
    Journal Article

    Lyons, T. G.; Dickler, M. N.; Comen, E. E.
    Current Oncology Reports (2018)

    Fulltext@MSK | Save
  • Perioperative immunotherapy in muscle-invasive bladder cancer and upper tract urothelial carcinoma
    Journal Article

    Teo, M. Y.; Rosenberg, J. E.
    Urologic Clinics of North America (2018)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase I cohorts of CheckMate 143
    Journal Article

    Omuro, A.; Vlahovic, G.; Lim, M.; Sahebjam, S.; Baehring, J.; Cloughesy, T.; Voloschin, A.; Ramkissoon, S. H.; Ligon, K. L.; Latek, R.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials
    Journal Article

    Johnson, C. B.; Win, S. Y.
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
    Journal Article

    Brogden, K. A.; Parashar, D.; Hallier, A. R.; Braun, T.; Qian, F.; Rizvi, N. A.; Bossler, A. D.; Milhem, M. M.; Chan, T. A.; Abbasi, T.; more...
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
    Journal Article

    Fankhauser, C. D.; Schüffler, P. J.; Gillessen, S.; Omlin, A.; Rupp, N. J.; Rueschoff, J. H.; Hermanns, T.; Poyet, C.; Sulser, T.; Moch, H.; more...
    Oncotarget (2018)

    Fulltext@MSK | Save
  • Checkpoint inhibition in lymphoma
    Journal Article

    Shah, G. L.; Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2018)

    Fulltext@MSK | Save